Best Buy cracks into prescription-based medical devices
By HME News Staff
Updated 8:39 AM CDT, Tue October 10, 2023
RICHFIELD, Minn. – Best Buy will sell the Dexcom G7 continuous glucose monitoring system (CGM) to eligible customers through BestBuy.com, where they will be brought to a new platform, Wellness.BestBuyHealth.com, to complete the process.
It’s the first time the electronics giant will offer prescription-based medical devices to customers.
“Through our health and wellness categories at Best Buy, we make it easy to purchase any of our thousands of carefully curated technology products that help you stay healthy throughout every stage of your life,” the company stated in a press release. “And with the new CGM offering, we’re making the process of purchasing a CGM easier, too. The expansion also aligns perfectly with the goal of Best Buy Health to enable care at home for everyone by relying on partners to provide care for patients while sticking to what we do best, providing technology and expertise that enriches and saves lives.”
Best Buy’s entry into the CGM market will be facilitated by Wheel, which will determine eligibility; HealthDyne, which will process prescriptions and have devices delivered; and Salesforce, which will power the new site with its Commerce Cloud.
At launch, Best Buy will not be able to accept insurance payment, though customers with HSA/FSA/HRA funds may be able to be reimbursed for their purchase. Additionally, the company will not be able to allow those with existing prescriptions from their physicians to upload that script into their profile and have a device sent to them, though it’s the goal to allow that in the future.
Best Buy also plans to expand CGM options beyond the Dexcom G7.
The company recently announced an expanded partnership with Geisinger to bring in-home care for patients with chronic conditions.
Comments